Intravenous Immune Globulin and Pseudohyponatremia
- 27 August 1998
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (9) , 632
- https://doi.org/10.1056/nejm199808273390914
Abstract
A 49-year-old woman admitted with typical Guillain–Barré syndrome was treated with intravenous immune globulin (Gamimune N 10%, Bayer, Elkhart, Ind.), at a dose of 45 g per day (0.4 g per kilogram of body weight) for five days.Keywords
This publication has 2 references indexed in Scilit:
- Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurological diseasesMuscle & Nerve, 1997
- Pseudohyponatremia: A reappraisalThe American Journal of Medicine, 1989